Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providersHematology & Oncology Physician in Richmond, VA
NPI: 1295945764Primary Practice Location
MEDICAL COLLEGE OF VIRGINIA HOSPITALS
1213 E Clay St, Richmond, VA
Primary Employer
MCV Associated Physicians
vcuhealth.org
HQ Phone
Get M.D. Hetal's Phone Numberphone_androidMobile
Get M.D. Hetal's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardMI State Medical License
VA State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 104 | 168 |
| 2 | 99213Established patient office or other outpatient visit, typically 15 minutes | 70 | 87 |
| 3 | 99215Established patient office or other outpatient, visit typically 40 minutes | 59 | 78 |
| 4 | 99205New patient office or other outpatient visit, typically 60 minutes | 18 | 18 |
| 5 | 99232Subsequent hospital inpatient care, typically 25 minutes per day | 17 | 41 |
Use of Olaparib in the Management of Metastatic Parathyroid Carcinoma With BRCA1 Mutation.
Authors: Woodfield, David, Le, Trang, Prince, Grace, Lee, Hyun, Vachhani, Hetal, Majety, Priyanka
Journal: JCEM Case Rep
Publication Date: 2025-02-17
Authors: Radwan, Rotana M, Schuster, Anne L R, Hertz, Daniel L, Lustberg, Maryam B, Vachhani, Hetal R, Hickey Zacholski, Erin, Sheppard, Vanessa B, Bridges, John F P, Salgado, Teresa M
Journal: Breast Cancer Res Treat
Publication Date: 2025-05-13
Authors: Radwan, Rotana M, Bridges, John F P, Hertz, Daniel L, Lustberg, Maryam B, Vachhani, Hetal, Hickey Zacholski, Erin, Sheppard, Vanessa B, Salgado, Teresa M
Journal: Support Care Cancer
Publication Date: 2025-05-10
Lead Sponsor: Alliance for Clinical Trials in Oncology
Collaborators: National Cancer Institute (NCI), Seagen Inc.
Intervention / Treatment: OTHER: Questionnaire Administration, OTHER: Quality-of-Life Assessment, DRUG: Placebo Administration, BIOLOGICAL: Trastuzumab Emtansine, DRUG: Tucatinib
Lead Sponsor: ECOG-ACRIN Cancer Research Group
Collaborators: National Cancer Institute (NCI)
Intervention / Treatment: DRUG: Docetaxel, RADIATION: Radiation Therapy, DRUG: Paclitaxel, BIOLOGICAL: Trastuzumab, DRUG: Nab-paclitaxel, PROCEDURE: Lumpectomy, BIOLOGICAL: Trastuzumab Emtansine, PROCEDURE: Mastectomy, BIOLOGICAL: Pertuzumab
Lead Sponsor: National Cancer Institute (NCI)
Collaborators: NRG Oncology
Intervention / Treatment: PROCEDURE: Magnetic Resonance Imaging, DRUG: Docetaxel, OTHER: Quality-of-Life Assessment, DRUG: Atezolizumab, DRUG: Paclitaxel, OTHER: Placebo Administration, PROCEDURE: Computed Tomography, BIOLOGICAL: Trastuzumab, PROCEDURE: Biopsy, PROCEDURE: Bone Scan, BIOLOGICAL: Pertuzumab
